Barry Baines

Okay. Yeah. Barry. Yeah. Dr. Patton, can you just help us to differentiate between nicotine, which is the addictive substance that's in tobacco products, but obviously nicotine pouches and e-cigarettes, et cetera. But between that and tobacco, because it's the nicotine addiction that that gets people hooked and, you know, having them continue to use those products.

Okay. Yeah. Barry. Yeah. Dr. Patton, can you just help us to differentiate between nicotine, which is the addictive substance that's in tobacco products, but obviously nicotine pouches and e-cigarettes, et cetera. But between that and tobacco, because it's the nicotine addiction that that gets people hooked and, you know, having them continue to use those products.

Uh, but for tobacco, a lot of the, uh, really bad health effects, um, relate not to the necessarily the nicotine, but as you were just pointing out the burn, you know, the burn products and what that does to lung tissue and all those kinds of things. But aren't they, I mean, they're related obviously. Um, but can you differentiate between the two? In other words, are we

Uh, but for tobacco, a lot of the, uh, really bad health effects, um, relate not to the necessarily the nicotine, but as you were just pointing out the burn, you know, the burn products and what that does to lung tissue and all those kinds of things. But aren't they, I mean, they're related obviously. Um, but can you differentiate between the two? In other words, are we

dealing with two different issues that we need to attack to sort of improve health overall in our communities between, again, nicotine and tobacco products, of which it's more overlapped.

dealing with two different issues that we need to attack to sort of improve health overall in our communities between, again, nicotine and tobacco products, of which it's more overlapped.

I think, you know, as a family physician, the way that played out is not so much certainly having the hammer of the information that this is all bad for you. But these are kind of things, just like with youth, that it's years, you know, it's years from now. And people are living in today, you know, mostly not, you know, what's going to happen 20 or 30 years. or 40 years from now.

I think, you know, as a family physician, the way that played out is not so much certainly having the hammer of the information that this is all bad for you. But these are kind of things, just like with youth, that it's years, you know, it's years from now. And people are living in today, you know, mostly not, you know, what's going to happen 20 or 30 years. or 40 years from now.

But for me, I think one of the biggest breakthroughs was actually more on the behavioral aspect of things is this whole idea of, yes, you give the information, but what's almost as important, if not more important, is to get an understanding of people's readiness to change their behavior. And there's a lot of public health work done for readiness to change.

But for me, I think one of the biggest breakthroughs was actually more on the behavioral aspect of things is this whole idea of, yes, you give the information, but what's almost as important, if not more important, is to get an understanding of people's readiness to change their behavior. And there's a lot of public health work done for readiness to change.

And every resident today, and certainly in primary care for sure, knows how to help assess their patient's readiness to change when they identify health behaviors, not just tobacco products usage, but other things as well. Because the threat of disease, that's a scare tactic, right? You want to scare people out of it.

And every resident today, and certainly in primary care for sure, knows how to help assess their patient's readiness to change when they identify health behaviors, not just tobacco products usage, but other things as well. Because the threat of disease, that's a scare tactic, right? You want to scare people out of it.

And when you're dealing with an addictive substance like nicotine, scare tactics don't necessarily work very well. But trying to work on people's motivation and realize that it's not going to be better quit today or, you know, or else. But really that it's a process and having that relationship over time and keep checking in, keep checking in. And over time, people sort of get the message.

And when you're dealing with an addictive substance like nicotine, scare tactics don't necessarily work very well. But trying to work on people's motivation and realize that it's not going to be better quit today or, you know, or else. But really that it's a process and having that relationship over time and keep checking in, keep checking in. And over time, people sort of get the message.

So there's that piece from a clinical perspective. What struck me, and again, I'll ask Dr. Patton about this. I remember seeing these graphs that was almost linear, that as taxing tobacco products, the level of taxes on tobacco products go up, usage goes down. I remember seeing these graphs, it was like,

So there's that piece from a clinical perspective. What struck me, and again, I'll ask Dr. Patton about this. I remember seeing these graphs that was almost linear, that as taxing tobacco products, the level of taxes on tobacco products go up, usage goes down. I remember seeing these graphs, it was like,

you know, taxes are going up and usage goes down, especially with youth, because they oftentimes don't have the financial resources to afford the escalating price. And that has been, you know, I mean, please correct me if I'm wrong, one of the biggest or most successful deterrents for tobacco product use in certainly in younger folks and probably other populations as well. So I hope

you know, taxes are going up and usage goes down, especially with youth, because they oftentimes don't have the financial resources to afford the escalating price. And that has been, you know, I mean, please correct me if I'm wrong, one of the biggest or most successful deterrents for tobacco product use in certainly in younger folks and probably other populations as well. So I hope

Clarence and Stan, I kind of addressed the piece with how that information about health effects is just one piece of the puzzle. It's so complicated. You really need a combined strategy. And it's persistence. You have to keep coming back to it to get the message across.

Clarence and Stan, I kind of addressed the piece with how that information about health effects is just one piece of the puzzle. It's so complicated. You really need a combined strategy. And it's persistence. You have to keep coming back to it to get the message across.